Welcome to our dedicated page for Ipg Photonics news (Ticker: IPGP), a resource for investors and traders seeking the latest updates and insights on Ipg Photonics stock.
IPG Photonics Corporation reports developments tied to its vertically integrated fiber laser and photonics manufacturing business, including high-performance fiber lasers, diode lasers, laser systems, amplifiers, optical components and complementary products used by OEMs, system integrators and end users. Company updates commonly discuss Industrial Solutions and Advanced Solutions, materials processing, welding, cutting, additive and battery manufacturing, medical and advanced applications, regional demand, tariffs, product costs and capital spending.
News also covers IPG Defense and the CROSSBOW™ high-energy laser counter-UAS system, customer orders and industry events for directed-energy products. Other recurring topics include patent litigation and settlements involving adjustable mode beam lasers, quarterly results, bookings, gross margin trends and operational initiatives.
IPG Photonics (Nasdaq: IPGP) will release its second quarter 2026 financial results before the market opens on Tuesday, August 4, 2026. The company will host a conference call at 10:00 a.m. ET, with phone dial-in options and a live webcast available via its investor relations website.
IPG Photonics (NASDAQ: IPGP) announced a binding offer to acquire Lumibird Medical for a cash purchase price of €300 million on a cash-free, debt-free basis, plus an earnout of up to €50 million tied to 2026–2027 performance. According to IPG Photonics, the deal will be funded entirely with cash on hand and is expected to be accretive to gross margin, EBITDA and adjusted EPS.
The acquisition is intended to expand IPG’s Advanced Solutions medical platform, combining its urology strength with Lumibird Medical’s ophthalmology leadership and adding an estimated $1 billion to IPG’s addressable market. Lumibird Medical generated €112.2 million revenue and €24.1 million EBITDA (21.5% margin) in 2025 and employs over 450 people across three global facilities. Following French works council consultation and customary conditions, closing is expected in Q4 2026.
IPG Photonics (NASDAQ: IPGP) announced a global settlement with TRUMPF resolving and dismissing all patent litigation worldwide between the parties as of May 5, 2026.
The agreement ends ongoing disputes and dismisses related cases; contact details for investor relations were provided by the company.
IPG Photonics (NASDAQ: IPGP) reported Q1 2026 results for the period ended March 31, 2026. Revenue was $265.5 million, up 17% year‑over‑year; GAAP gross margin was 37.5% and adjusted EBITDA was $35.2 million. Industrial Solutions represented 86% of revenue and rose 21% year‑over‑year. The company provided Q2 2026 guidance of $260M–$290M revenue and adjusted EPS of $0.25–$0.55. Management noted tariff pressures, higher product costs and FX effects on margins.
IPG Photonics (Nasdaq: IPGP) will report first quarter 2026 financial results before the market opens on Tuesday, May 5, 2026.
The company will host a conference call at 10:00 a.m. ET the same day; dial-in numbers and a live webcast will be available and archived on the investor relations website.
IPG Photonics (NASDAQ:IPGP) announced that IPG Defense will exhibit at AUSA Global Force Symposium & Exposition in Huntsville, Alabama, from March 24–26, 2026. IPG Defense will showcase CROSSBOW™ HEL counter-UAS systems and host expert staff to demonstrate laser-based directed energy solutions for drone threats.
The Huntsville presence follows the opening of a local IPG Defense facility to increase customer access and engagement with military and private-sector attendees.
IPG Photonics (NASDAQ: IPGP) said the Local Division of the Unified Patent Court in Düsseldorf ruled certain uses and designs of its adjustable mode beam (AMB) lasers infringe European Patent 2,624,031. The decision covers AMB products sold in Germany, France and Italy and affects less than 1% of total sales.
IPG will implement contingency measures for AMB customers, intends to appeal to the UPC Court of Appeal, and notes other laser models remain broadly available.
IPG Photonics (NASDAQ:IPGP) received an approximately $10 million order from Lockheed Martin for delivery of CROSSBOW™ high-energy laser counter-UAS systems, with shipments expected over the next several quarters.
The company said the follow-on order reflects continued demand for its scalable, deployable directed-energy solutions and the readiness of the CROSSBOW product.
IPG Photonics (NASDAQ: IPGP) said the Local Division of the Unified Patent Court in Mannheim ruled certain designs of its adjustable mode beam (AMB) lasers infringe European Patent 2,951,625.
The decision covers AMB products sold in seven UPC member states, including Germany, France and Italy, and affects less than 1% of IPG's total sales. IPG plans to appeal and is implementing contingency measures to support AMB customers while its broader product portfolio remains available.
IPG Photonics (NASDAQ: IPGP) reported fourth-quarter 2025 revenue of $274.5 million, up 17% year-over-year, and full-year revenue of $1,003.8 million, up 3%.
GAAP gross margin fell to 36.1% due to higher product costs and tariffs; adjusted EBITDA was $41.2 million. The board authorized a $100 million share repurchase program. Q1 2026 guidance: revenue $235M–$265M, adjusted gross margin 37%–39%, operating expenses $90M–$92M, adjusted EPS $0.10–$0.40.